TerminatedPHASE2, PHASE3NCT02790034
Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
Studying Rett syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Newron Pharmaceuticals SPA
- Principal Investigator
- Ravi Anand, MD, MDNewron Pharmaceuticals
- Intervention
- Sarizotan low dose(drug)
- Enrollment
- 129 enrolled
- Eligibility
- 4 years · All sexes
- Timeline
- 2016 – 2020
Study locations (14)
- University of Alabama, Birmingham, Alabama, United States
- University of California, San Diego, California, United States
- Rush University Medical Center, Chicago, Illinois, United States
- Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, United States
- Baylor College of Medicine, Houston, Texas, United States
- South Metropolitan Health Service Fiona Stanley Hospital, Murdoch, Western Australia, Australia
- Amrita Institute of Medical Sciences, Kochi, Kerala, India
- Vijaya Health Centre, Chennai, Tamil Nadu, India
- P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, India
- Jaslok Hospital and Research centre, Mumbai, India
- All India Institute of Medical Sciences, New Delhi, India
- A.O.U. Senese Policlinico Santa Maria alle Scotte, Siena, Tuscany, Italy
- U.O. Neuropsichiatria Infantile, Milan, Italy
- King's College Hospital, London, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02790034 on ClinicalTrials.govOther trials for Rett syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06840496To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett SyndromeBiomed Industries, Inc.
- RECRUITINGPHASE2NCT07430046Repurposing Mirtazapine in Rett SyndromeUniversity of Trieste
- RECRUITINGNCT06338267Validating Innovative Biosensors for Rett Autonomic Symptom TrackingRett Syndrome Research Trust
- RECRUITINGEARLY PHASE1NCT06856759Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett SyndromeGuangzhou Women and Children's Medical Center
- RECRUITINGNCT06705816Cognitive Function in Rett Syndrome During Trofinetide TreatmentUniversity of Minnesota
- ENROLLING BY INVITATIONNANCT06739434GCB-002 in Treatment of Patients With Rett SyndromeGenecombio Ltd.
- ACTIVE NOT RECRUITINGNANCT07418905Technology-supported Motor Rehabilitation for People With Rett SyndromeGeorgetown University
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT06152237Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study)Taysha Gene Therapies, Inc.